Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome

Davide Bedognetti, Ena Wang, Francesco M. Marincola

Research output: Contribution to journalEditorial

8 Citations (Scopus)
Original languageEnglish
Article numbere28727
JournalOncoImmunology
Volume3
Issue number4
DOIs
Publication statusPublished - 2014
Externally publishedYes

Keywords

  • Biomarkers
  • Breast cancer
  • CXCL-13
  • gene signature
  • Gene-expression
  • Immunotherapy
  • Melanoma
  • Neoadjuvant chemotherapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology

Cite this